ProfileGDS2244 / 208018_s_at
TitleMelanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OrganismHomo sapiens


E2F-1 doxorubicin E2F-1 and doxorubicin GSM52504 GSM52508 GSM52518 GSM52519 GSM52516 GSM52517 30% 34% 30% 31% 30% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM52504SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1)11.230
GSM52508SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2)13.834
GSM52518SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1)11.430
GSM52519SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2)12.131
GSM52516SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1)12.230
GSM52517SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2)18.939